SCHEMBL1473035

SCHEMBL1473035

OCc1ccc(-c2ccc3nc(-c4ccc(-c5ccccc5)cc4)cn3c2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A3 P47895 11/20 0.77
ALDH1A1 P00352 8/20 0.77
ALDH1A2 O94788 1/20 0.77
SLC2A1 P11166 1/20 0.68
NR4A2 P43354 2/20 0.64
CYP2C9 P11712 1/20 0.64
KCNH2 Q12809 1/20 0.64
NPC1 O15118 5/20 0.55
RAB9A P51151 5/20 0.55
KDM4E B2RXH2 4/20 0.55
HPGD P15428 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
PKM P14618 2/20 0.55
KMT2A Q03164 2/20 0.55
TP53 P04637 1/20 0.55
TSHR P16473 1/20 0.55
CDK5 Q00535 1/20 0.55
CDK5R1 Q15078 1/20 0.55
HSD17B10 Q99714 1/20 0.55
POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1472442 1.00 ALDH1A3 (0.77) ALDH1A3ALDH1A1ALDH1A2SLC2A1NR4A2
SCHEMBL13325768 0.87 ALDH1A3 (1.00) ALDH1A3ALDH1A1ALDH1A2SLC2A1NR4A2
SCHEMBL1472422 0.87 NR4A2 (0.83) ALDH1A3ALDH1A1ALDH1A2SLC2A1NR4A2
SCHEMBL3433041 0.83 ALDH1A3 (0.52) ALDH1A3ALDH1A1ALDH1A2SLC2A1NR4A2
SCHEMBL12970541 0.82 NPC1 (0.73) ALDH1A3ALDH1A1SLC2A1NR4A2CYP2C9
SCHEMBL16261617 0.81 ALDH1A3 (1.00) ALDH1A3ALDH1A1ALDH1A2SLC2A1NPC1
SCHEMBL220148 0.81 NR4A2 (0.60) ALDH1A3ALDH1A1ALDH1A2SLC2A1NR4A2
SCHEMBL1472921 0.81 NR4A2 (0.51) ALDH1A3ALDH1A1ALDH1A2SLC2A1NR4A2
SCHEMBL1472596 0.81 CYP2C9 (0.51) ALDH1A3ALDH1A1ALDH1A2SLC2A1NR4A2
SCHEMBL1472161 0.81 ALDH1A3 (0.70) ALDH1A3ALDH1A1ALDH1A2SLC2A1NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915284-B2 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof SANOFI-AVENTIS (FR) 2011-03-29 US claimed
US-20090253735-A1 2-ARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-10-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253735-A1 2-ARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF NCOR1, NR4A2, NR4A3 ALDH1A3 1043/4885ALDH1A1 1788/4885ALDH1A2 1466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.